Knox Lane, an investment firm focused on partnering with growth-oriented businesses in the services and consumer sectors, completed the investment in Spectrum Science, an independent, integrated marketing, communications and media firm. Financial terms were not disclosed. The partnership will support the continued expansion of Spectrum's strategic communications capabilities, while also enabling the Company to build on its unique approach to clinical trial recruitment, broaden consultative capabilities for medical affairs clients and drive enhanced tech enablement throughout the organization.